CLMT.NASDAQCalumet, INC /DE

Form 4: Calumet Director Stephen Mawer Granted 13,780 Restricted Stock Units

Sentiment:

Insider Transaction Report


Calumet, Inc. Director Stephen P. Mawer has been granted 13,780 Restricted Stock Units (RSUs) as part of his compensation, aligning his interests with shareholders.

Summary

  • Stephen P. Mawer, a Director of Calumet, Inc. (CLMT), was granted 13,780 Restricted Stock Units (RSUs).
  • The transaction date for this grant was June 11, 2025.
  • Each RSU is economically equivalent to one share of Calumet, Inc. common stock.
  • The RSUs will vest upon the earlier of June 11, 2026, or the date of Calumet, Inc.'s Annual Meeting in 2026.
  • Upon vesting, the Restricted Stock Units will be settled.

Sentiment

Score: 6

Explanation: The sentiment is mildly positive as the RSU grant aligns director interests with shareholders, which is generally viewed favorably. However, it's a routine compensation event and not indicative of significant operational or financial news.

Positives

  • The grant of Restricted Stock Units to a director helps align the director's financial interests with those of the company's shareholders, encouraging long-term value creation.
  • Equity compensation is a standard practice for attracting and retaining qualified board members.

Future Outlook

The grant of Restricted Stock Units with a future vesting date indicates a continued commitment to aligning director incentives with long-term company performance and shareholder value.

Industry Context

The granting of Restricted Stock Units (RSUs) to directors is a common and widely accepted practice in corporate governance across various industries, including the energy and specialty products sector where Calumet, Inc. operates. This form of equity compensation is designed to align the interests of board members with those of shareholders by tying a portion of their compensation to the company's stock performance over time.

Comparison to Industry Standards

  • The use of Restricted Stock Units (RSUs) for director compensation is a standard practice, comparable to compensation structures seen in many publicly traded companies across the U.S. market.
  • The grant of 13,780 RSUs to a director is within typical ranges for non-executive director equity compensation, though specific amounts vary widely based on company size, industry, and board responsibilities.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorNAStephen P. MawerNAThis document reports an equity grant to an existing director, not a change in management.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation StructureThe grant of Restricted Stock Units to a director is part of the company's ongoing equity compensation program for its board members.06/11/2025Reinforces alignment between director incentives and long-term shareholder value.

Related Party Transactions

  • The grant of Restricted Stock Units to Stephen P. Mawer, a Director of Calumet, Inc., constitutes a related party transaction as it involves compensation from the company to an insider.

Stakeholder Impact

  • Shareholders: The RSU grant aims to align the director's interests with shareholders, potentially leading to better long-term decision-making and value creation.
  • Employees: No direct impact on employees is indicated by this specific filing.

Next Steps

  • The Restricted Stock Units will vest upon the earlier of June 11, 2026, or the date of Calumet, Inc.'s Annual Meeting in 2026.
  • Upon vesting, the Restricted Stock Units will be settled into common stock.

Key Dates

DateDescription
06/11/2025Date of transaction for the Restricted Stock Unit grant to Stephen P. Mawer.
06/11/2026Earliest potential vesting date for the Restricted Stock Units.
06/13/2025Date the Form 4 filing was signed by the attorney-in-fact for Stephen P. Mawer.

Keywords

Calumet Inc., CLMT, Restricted Stock Units, RSU, Director Compensation, Equity Grant, SEC Form 4, Insider Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.